Financial Snapshot

Revenue
$750.0K
TTM
Gross Margin
Net Earnings
-$12.70M
TTM
Current Assets
Q2 2024
Current Liabilities
Q2 2024
Current Ratio
15.7%
Q2 2024
Total Assets
Q2 2024
Total Liabilities
Q2 2024
Book Value
-$6.238M
Q2 2024
Cash
Q2 2024
P/E
-0.03582
Nov 29, 2024 EST
Free Cash Flow
-$5.237M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002
Revenue $60.00K $450.0K $614.0K $799.0K $806.0K $556.0K $944.0K $1.159M $1.350M $2.800M $3.778M $41.38M $1.425M $448.0K $1.425M $1.560M $1.680M $4.590M $2.780M $3.680M $2.380M $1.990M
YoY Change -86.67% -26.71% -23.15% -0.87% 44.96% -41.1% -18.55% -14.15% -51.79% -25.89% -90.87% 2803.93% 218.08% -68.56% -8.65% -7.14% -63.4% 65.11% -24.46% 54.62% 19.6% 352.27%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002
Revenue $60.00K $450.0K $614.0K $799.0K $806.0K $556.0K $944.0K $1.159M $1.350M $2.800M $3.778M $41.38M $1.425M $448.0K $1.425M $1.560M $1.680M $4.590M $2.780M $3.680M $2.380M $1.990M
Cost Of Revenue $660.0K $1.482M $1.908M $1.030M $0.00 $23.67M $24.47M $24.67M $19.90M $11.24M $5.980M $5.430M $6.200M $4.410M
Gross Profit $690.0K $1.318M $1.870M $40.35M $1.430M -$23.23M -$23.05M -$23.11M -$18.22M -$6.650M -$3.200M -$1.750M -$3.820M -$2.420M
Gross Profit Margin 51.11% 47.07% 49.5% 97.51% 100.35% -5185.27% -1617.54% -1481.41% -1084.52% -144.88% -115.11% -47.55% -160.5% -121.61%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002
Selling, General & Admin $6.154M $6.151M $6.105M $5.047M $4.554M $5.092M $5.630M $5.737M $7.217M $10.81M $11.61M $13.25M $15.84M $15.71M $15.68M $15.78M $15.60M $10.88M $3.830M $3.250M $2.690M $2.640M
YoY Change 0.05% 0.75% 20.96% 10.83% -10.57% -9.56% -1.87% -20.51% -33.21% -6.92% -12.36% -16.39% 0.81% 0.2% -0.61% 1.15% 43.38% 184.07% 17.85% 20.82% 1.89% -12.58%
% of Gross Profit 1045.94% 819.8% 620.75% 32.82% 1107.76%
Research & Development $8.323M $7.750M $6.060M $5.360M $4.850M $4.780M $4.600M $5.670M $6.600M $17.34M $18.80M $23.18M $24.45M
YoY Change 7.39% 27.89% 13.06% 10.52% 1.46% 3.91% -18.87% -14.09% -61.94% -7.77% -18.9% -5.19%
% of Gross Profit 956.52% 1315.63% 1005.35% 57.45% 1709.79%
Depreciation & Amortization $290.0K $263.0K $220.0K $182.0K $203.0K $196.0K $206.0K $515.0K $265.0K $507.0K $928.0K $1.298M $1.507M $1.647M $2.734M $3.730M $1.450M $960.0K $320.0K $270.0K $310.0K
YoY Change 10.27% 19.55% 20.88% -10.34% 3.57% -4.85% -60.0% 94.34% -47.73% -45.37% -28.51% -13.87% -8.5% -39.76% -26.7% 157.24% 51.04% 200.0% 18.52% -12.9%
% of Gross Profit 38.41% 38.47% 49.63% 3.22% 105.38%
Operating Expenses $14.48M $6.151M $6.105M $5.047M $4.554M $5.092M $5.630M $5.737M $7.217M $10.81M $11.61M $13.25M $15.84M $15.71M $15.68M $15.78M $15.60M $10.87M $3.830M $3.250M $2.700M $2.640M
YoY Change 135.36% 0.75% 20.96% 10.83% -10.57% -9.56% -1.87% -20.51% -33.21% -6.92% -12.36% -16.39% 0.81% 0.2% -0.61% 1.15% 43.51% 183.81% 17.85% 20.37% 2.27% -12.58%
Operating Profit -$14.42M -$13.45M -$11.69M -$9.609M -$8.596M -$9.319M -$9.283M -$10.25M -$12.47M -$26.83M -$28.54M $3.929M -$38.86M -$38.94M -$38.73M -$38.89M -$33.82M -$17.52M -$7.030M -$5.000M -$6.520M -$5.060M
YoY Change 7.18% 15.04% 21.68% 11.78% -7.76% 0.39% -9.42% -17.81% -53.52% -6.0% -826.39% -110.11% -0.2% 0.54% -0.41% 14.99% 93.04% 149.22% 40.6% -23.31% 28.85% -43.08%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002
Interest Expense $0.00 $700.0K -$960.0K $9.640M $160.0K $5.000K $7.000K $51.00K $124.0K $156.0K $136.0K $772.0K $2.890M $5.940M $1.460M -$600.0K -$50.00K -$130.0K -$120.0K
YoY Change -100.0% -172.92% -109.96% 5925.0% -28.57% -86.27% -58.87% -20.51% 14.71% -82.38% -73.29% -51.35% 306.85% -343.33% 1100.0% -61.54% 8.33% 200.0%
% of Operating Profit 3.16%
Other Income/Expense, Net -$38.00K $41.00K $697.0K -$541.0K -$4.614M $134.0K -$113.0K -$38.00K $62.00K $61.00K -$4.000K $27.00K $76.00K
YoY Change -192.68% -94.12% -228.84% -88.27% -3543.28% -218.58% 197.37% -161.29% 1.64% -1625.0% -114.81% -64.47%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002
Pretax Income -$14.46M -$13.41M -$11.00M -$10.15M -$13.21M -$9.185M -$9.396M -$10.29M -$12.44M -$28.74M -$28.20M $3.502M -$38.87M -$38.80M -$37.96M -$36.01M -$27.88M -$16.06M -$7.630M -$5.060M -$6.640M -$5.190M
YoY Change 7.79% 21.96% 8.33% -23.16% 43.82% -2.25% -8.65% -17.32% -56.72% 1.92% -905.25% -109.01% 0.19% 2.21% 5.42% 29.16% 73.6% 110.48% 50.79% -23.8% 27.94% -41.95%
Income Tax $0.00 $156.0K $36.00K $56.00K -$254.0K $0.00 $0.00 -$1.097M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$14.46M -$13.57M -$11.03M -$10.21M -$12.96M -$9.185M -$9.396M -$7.604M -$23.68M -$29.53M -$30.51M $3.630M -$38.79M -$38.80M -$37.96M -$36.01M -$27.88M -$16.06M -$7.630M -$5.060M -$6.640M -$5.190M
YoY Change 6.55% 22.98% 8.08% -21.23% 41.06% -2.25% 23.57% -67.89% -19.82% -3.19% -940.39% -109.36% -0.03% 2.21% 5.42% 29.16% 73.6% 110.48% 50.79% -23.8% 27.94% -41.95%
Net Earnings / Revenue -24091.67% -3014.67% -1796.58% -1277.35% -1607.44% -1651.98% -995.34% -656.08% -1754.15% -1054.79% -807.46% 8.77% -2722.11% -8660.71% -2663.86% -2308.33% -1659.52% -349.89% -274.46% -137.5% -278.99% -260.8%
Basic Earnings Per Share -$1.82 -$2.76 -$2.33 -$4.30 -$3.29 -$2.73 -$0.95 -$2.88 -$5.31 $0.11 -$1.24 -$1.45
Diluted Earnings Per Share -$1.82 -$2.76 -$2.33 -$4.30 -$36.00M -$36.76M -$117.5M -$108.6M -$394.7M -$0.48 -$0.88 $0.11 -$1.24 -$1.45 -$3.796B -$3.601B -$2.788B -$1.606B -$763.0M -$506.0M -$664.0M -$519.0M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002
Cash & Short-Term Investments $1.068M $4.347M $15.99M $9.700M $11.10M $5.800M $14.50M $7.300M $12.30M $20.00M $19.20M $43.80M $76.90M $61.60M $92.20M $91.10M $109.3M $122.1M $3.200M $4.500M
YoY Change -75.43% -72.81% 64.85% -12.61% 91.38% -60.0% 98.63% -40.65% -38.5% 4.17% -56.16% -43.04% 24.84% -33.19% 1.21% -16.65% -10.48% 3715.63% -28.89%
Cash & Equivalents $1.068M $2.356M $5.329M $3.400M $5.400M $3.000M $14.50M $7.300M $12.30M $20.00M $7.700M $14.60M $21.30M $12.50M $10.80M $26.20M $22.70M $25.20M $1.800M $3.200M
Short-Term Investments $0.00 $1.991M $10.66M $6.300M $5.700M $2.700M $11.50M $29.20M $55.60M $49.00M $81.40M $64.90M $86.60M $96.90M $1.300M $1.300M
Other Short-Term Assets $332.0K $641.0K $436.0K $500.0K $500.0K $400.0K $300.0K $400.0K $2.000M $800.0K $2.900M $700.0K $800.0K $800.0K $800.0K $500.0K $700.0K $700.0K $100.0K $500.0K
YoY Change -48.21% 47.02% -12.8% 0.0% 25.0% 33.33% -25.0% -80.0% 150.0% -72.41% 314.29% -12.5% 0.0% 0.0% 60.0% -28.57% 0.0% 600.0% -80.0%
Inventory $0.00 $100.0K $600.0K $1.900M $3.200M
Prepaid Expenses
Receivables $0.00 $30.00K $198.0K $100.0K $100.0K $200.0K $100.0K $200.0K $500.0K $600.0K $1.200M $1.300M $800.0K $800.0K $400.0K $200.0K $1.500M $700.0K $500.0K $400.0K
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $1.400M $5.018M $16.62M $10.30M $11.70M $6.400M $14.90M $7.900M $14.90M $22.00M $25.20M $49.00M $78.40M $63.30M $93.40M $91.80M $111.5M $123.4M $3.800M $5.400M
YoY Change -72.1% -69.81% 61.4% -11.97% 82.81% -57.05% 88.61% -46.98% -32.27% -12.7% -48.57% -37.5% 23.85% -32.23% 1.74% -17.67% -9.64% 3147.37% -29.63%
Property, Plant & Equipment $2.201M $2.736M $3.244M $3.600M $4.400M $6.200M $1.500M $1.700M $100.0K $500.0K $800.0K $1.400M $2.300M $2.800M $3.500M $4.400M $6.900M $3.700M $3.000M $1.400M
YoY Change -19.55% -15.66% -9.89% -18.18% -29.03% 313.33% -11.76% 1600.0% -80.0% -37.5% -42.86% -39.13% -17.86% -20.0% -20.45% -36.23% 86.49% 23.33% 114.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.500M $1.500M $0.00 $700.0K
YoY Change 66.67%
Other Assets $306.0K $331.0K $547.0K $500.0K $700.0K $400.0K $400.0K $1.100M $2.100M $700.0K $700.0K $700.0K $700.0K $700.0K $700.0K $700.0K $600.0K $500.0K $600.0K $0.00
YoY Change -7.55% -39.49% 9.4% -28.57% 75.0% 0.0% -63.64% -47.62% 200.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 16.67% 20.0% -16.67%
Total Long-Term Assets $2.507M $3.067M $3.791M $4.200M $5.000M $6.600M $2.000M $2.800M $2.200M $1.100M $1.500M $4.500M $4.500M $3.500M $4.200M $5.100M $7.500M $4.200M $3.500M $2.100M
YoY Change -18.26% -19.1% -9.74% -16.0% -24.24% 230.0% -28.57% 27.27% 100.0% -26.67% -66.67% 0.0% 28.57% -16.67% -17.65% -32.0% 78.57% 20.0% 66.67%
Total Assets $3.907M $8.085M $20.42M $14.50M $16.70M $13.00M $16.90M $10.70M $17.10M $23.10M $26.70M $53.50M $82.90M $66.80M $97.60M $96.90M $119.0M $127.6M $7.300M $7.500M
YoY Change
Accounts Payable $1.202M $109.0K $83.00K $100.0K $300.0K $100.0K $100.0K $100.0K $100.0K $300.0K $600.0K $1.200M $500.0K $200.0K $600.0K $900.0K $300.0K $1.600M $1.300M $1.500M
YoY Change 1002.75% 31.33% -17.0% -66.67% 200.0% 0.0% 0.0% 0.0% -66.67% -50.0% -50.0% 140.0% 150.0% -66.67% -33.33% 200.0% -81.25% 23.08% -13.33%
Accrued Expenses $2.679M $1.501M $1.650M $1.800M $1.900M $1.500M $2.300M $2.700M $3.500M $3.700M $4.900M $3.500M $3.600M $4.100M $3.700M $3.600M $4.200M $1.400M $800.0K $700.0K
YoY Change 78.48% -9.03% -8.33% -5.26% 26.67% -34.78% -14.81% -22.86% -5.41% -24.49% 40.0% -2.78% -12.2% 10.81% 2.78% -14.29% 200.0% 75.0% 14.29%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $984.0K $0.00 $100.0K $400.0K
YoY Change -100.0% -75.0%
Total Short-Term Liabilities $4.865M $1.610M $1.733M $1.800M $2.200M $1.600M $2.400M $2.800M $3.900M $4.200M $6.200M $6.000M $7.200M $6.400M $4.600M $4.600M $4.700M $3.200M $3.000M $2.800M
YoY Change 202.17% -7.1% -3.72% -18.18% 37.5% -33.33% -14.29% -28.21% -7.14% -32.26% 3.33% -16.67% 12.5% 39.13% 0.0% -2.13% 46.88% 6.67% 7.14%
Long-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K
YoY Change -100.0%
Other Long-Term Liabilities $1.525M $2.075M $2.656M $3.200M $18.60M $5.600M $1.000M $1.600M $200.0K $200.0K $100.0K $200.0K $36.30M $36.70M $37.90M $33.20M $25.10M $14.80M $6.900M $4.400M
YoY Change -26.51% -21.88% -17.0% -82.8% 232.14% 460.0% -37.5% 700.0% 0.0% 100.0% -50.0% -99.45% -1.09% -3.17% 14.16% 32.27% 69.59% 114.49% 56.82%
Total Long-Term Liabilities $1.525M $2.075M $2.656M $3.200M $18.60M $5.600M $1.000M $1.600M $200.0K $200.0K $100.0K $200.0K $36.30M $36.70M $37.90M $33.20M $25.10M $14.80M $6.900M $4.500M
YoY Change -26.51% -21.88% -17.0% -82.8% 232.14% 460.0% -37.5% 700.0% 0.0% 100.0% -50.0% -99.45% -1.09% -3.17% 14.16% 32.27% 69.59% 114.49% 53.33%
Total Liabilities $6.390M $3.685M $4.389M $5.000M $20.80M $7.300M $3.400M $4.400M $4.100M $4.300M $6.300M $6.200M $43.40M $43.10M $42.50M $37.90M $29.80M $18.00M $9.900M $7.200M
YoY Change 73.41% -16.04% -12.22% -75.96% 184.93% 114.71% -22.73% 7.32% -4.65% -31.75% 1.61% -85.71% 0.7% 1.41% 12.14% 27.18% 65.56% 81.82% 37.5%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $455.02 Thousand

About YIELD10 BIOSCIENCE, INC.

Yield10 Bioscience Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Woburn, Massachusetts and currently employs 29 full-time employees. The company went IPO on 2006-11-10. Yield10 Bioscience, Inc. is an agricultural bioscience company that is leveraging advanced genetics to develop the oilseed Camelina sativa (Camelina) as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and aquafeed applications; and PHA bioplastics for use as biodegradable bioplastics. The firm is pursuing Camelina seed oil products for two market opportunities and value chains. The first product is seed oil produced by Camelina, which is genetically engineered to enable production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA). The second product is Camelina seed oil for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD) and sustainable aviation fuel (SAF).

Industry: Agricultural Production-Crops Peers: ABEONA THERAPEUTICS INC. Theriva Biologics, Inc. Aptevo Therapeutics Inc. Cabaletta Bio, Inc. HUMANIGEN, INC NexImmune, Inc. KINETA, INC./DE RenovoRx, Inc. Sigilon Therapeutics, Inc.